Bill Search

  • Introduced
    Dec 13, 2023
  • Passed House
    Feb 29, 2024
  • Passed Senate
    Mar 05, 2024
  • Signed into Law
    Jun 18, 2024
HB 885
Florida House Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Coverage for Biomarker Testing; Requires DMS to provide coverage of biomarker testing for specified purposes for state employees' state group health insurance plan policies; authorizes AHCA to pay for biomarker testing under Medicaid program for specified purposes, subject to specific appropriations; requires managed care plans under contract with agency in Medicaid program to provide coverage for biomarker testing for Medicaid recipients in certain manner; specifies circumstances under which such coverage may be provided; requires clear, convenient, & readily accessible process for authorization requests for biomarker testing.
Last Action See all actions
legislature • Jun 19, 2024: Chapter No. 2024-249
Latest Bill Text See all bill texts

Official Summary/Bill Text

Comments on HB 885

Tweets

Whip Lists

Sponsors
Votes
Actions
  • Jun 19, 2024 | legislature
    • Chapter No. 2024-249
  • Jun 18, 2024 | legislature
    • Approved by Governor
  • Jun 17, 2024 | legislature
    • Signed by Officers and presented to Governor
  • Mar 05, 2024 | House
    • In Messages
    • Ordered enrolled
  • Mar 05, 2024 | Senate
    • Withdrawn from Fiscal Policy
    • Placed on Calendar, on 2nd reading
    • Substituted for CS/CS/SB 964
    • Read 2nd time
    • Read 3rd time
    • CS passed; YEAS 39 NAYS 0
  • Feb 29, 2024 | Senate
    • In Messages
    • Referred to Fiscal Policy
    • Received
  • Feb 29, 2024 | House
    • Read 2nd time
    • Amendment 718117 adopted
    • Added to Third Reading Calendar
    • Read 3rd time
    • CS passed as amended; YEAS 114, NAYS 0
  • Feb 26, 2024 | House
    • Bill referred to House Calendar
    • Bill added to Special Order Calendar (2/29/2024)
    • 1st Reading (Committee Substitute 2)
  • Feb 23, 2024 | House
    • Reported out of Health & Human Services Committee
    • Laid on Table under Rule 7.18(a)
    • CS Filed
  • Feb 22, 2024 | House
    • Favorable with CS by Health & Human Services Committee
  • Feb 20, 2024 | House
    • Added to Health & Human Services Committee agenda
  • Feb 08, 2024 | House
    • Favorable by Appropriations Committee
    • Reported out of Appropriations Committee
    • Now in Health & Human Services Committee
  • Feb 06, 2024 | House
    • Added to Appropriations Committee agenda
  • Jan 25, 2024 | House
    • 1st Reading (Committee Substitute 1)
    • Referred to Appropriations Committee
    • Referred to Health & Human Services Committee
    • Now in Appropriations Committee
  • Jan 24, 2024 | House
    • Laid on Table under Rule 7.18(a)
    • CS Filed
  • Jan 23, 2024 | House
    • Reported out of Select Committee on Health Innovation
  • Jan 22, 2024 | House
    • Favorable with CS by Select Committee on Health Innovation
  • Jan 18, 2024 | House
    • Added to Select Committee on Health Innovation agenda
  • Jan 09, 2024 | House
    • 1st Reading (Original Filed Version)
  • Dec 27, 2023 | House
    • Referred to Select Committee on Health Innovation
    • Referred to Appropriations Committee
    • Referred to Health & Human Services Committee
    • Now in Select Committee on Health Innovation
  • Dec 13, 2023 | House
    • Filed